yohimbine has been researched along with Acute Respiratory Distress Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Funayama, H; Murai, S; Nakamura, M; Otsuka, H; Saito, H; Sakai, M; Shikama, Y; Sugawara, S; Takada, H; Yokochi, T; Yu, Z | 1 |
| Fu, YM; Lu, DX; Qi, RB; Wang, HD; Wang, YP; Yan, YX; Zhang, HQ | 1 |
2 other study(ies) available for yohimbine and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Pulmonary platelet accumulation induced by catecholamines: Its involvement in lipopolysaccharide-induced anaphylaxis-like shock.
Topics: Anaphylaxis; Animals; Blood Platelets; Catecholamines; Cells, Cultured; Complement C5; Humans; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Prazosin; Respiratory Distress Syndrome; Serotonin; Yohimbine | 2017 |
Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice.
Topics: Animals; Berberine; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Lung Injury; Mice; Neutrophils; Phospholipases A2, Cytosolic; Phosphorylation; Pulmonary Edema; Receptors, Adrenergic, alpha-2; Respiratory Distress Syndrome; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2008 |